Regeneron Pharmaceuticals, Inc.
BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF
Last updated:
Abstract:
Provided herein are compounds, compositions and methods for the treatment of diseases and disorders associated with the liver X receptor, including bis-octahydrophenanthrene carboxamides and protein (e.g., antibody) drug conjugates thereof.
Status:
Application
Type:
Utility
Filling date:
5 Oct 2021
Issue date:
14 Apr 2022